Dr. Lu Xianping Recognized as EY Entrepreneur Of The Year™ in 2025 Dr. Lu Xianping, Chairman of Chipscreen Biosciences, has been awarded the EY Entrepreneur Of The Year™ 2025 for his impactful contributions to pharmaceuticals.

Dr. Lu Xianping Recognized as EY Entrepreneur Of The Year™ in 2025 #China #Shenzhen #EY_Entrepreneur #Chipscreen_Biosciences #Lu_Xianping

Chipscreen Biosciences Achieves FDA Approval for Groundbreaking Cancer Drug CS231295 Chipscreen Biosciences has received FDA IND approval for CS231295, a promising cancer treatment poised to advance clinical development globally.

Chipscreen Biosciences Achieves FDA Approval for Groundbreaking Cancer Drug CS231295 #China #Shenzhen #FDA_Approval #Chipscreen_Biosciences #CS231295